Abstract

Objective(s): Present investigations aimed to compare the anticancer and antioxidant activities of Sepia pharaonis ink extract (SIE) and Ellagic acid (EA) to cyclophosphamide (CP). Materials and Methods: Male Wistar Albino rats were grouped into five groups, each with ten rats. Control group (Group I) received (2 ml/kg 0.9% NaCl b.w. i.p.). Group II served as CP group was received (200 mg/kg CP b.w. i.p.). Rats of groups III, IV and V received (200 mg/kg CP b.w. i.p.) and treated with SIE (200 mg/kg b.w.), EA (60 mg/kg) and SIE (200 mg/kg b.w.) + EA (60 mg/kg), respectively. GSH, CAT, SOD, NO, and MDA levels were measured in all groups' liver and renal tissues. Histopathological examinations of the liver and kidney were performed. Results: In the liver and renal tissue homogenate of CP-treated animals, there was a highly significant reduction in GSH, CAT, and SOD, as well as a striking elevation of MDA and NO. In all treated animals with SIE, EA, and SIE+EA, however, there was a substantial decrease in liver and renal MDA and NO levels with a moderate increase in GSH, CAT, and SOD activities. After CP treatment, liver and kidney tissues showed extensive necrosis, but CP+ SIE+ EA treatment revealed regeneration of some hepatocytes and kidney cells. Conclusion: SIE and EA were both successful in reducing oxidative stress caused by CP. The effect and antitumor properties of SIE and EA as antioxidants were supported by histopathological examination in this study.

Highlights

  • The majority of chemotherapeutic drugs used to treat neoplastic cells harm normal living cells in different ways

  • Oxidative Stress Biomarkers in Liver and Kidney Tissues: Measurement of MDA as an indicator of lipid peroxidation revealed that CP highly significantly increased lipid peroxidation in liver and kidney tissues as estimated by increased MDA satisfied which existing in Figs 1& 2 and recorded a highly significant increase at (p

  • Ellagic acid (EA) treatment for 30 days appearances a highly increase (p

Read more

Summary

Introduction

The majority of chemotherapeutic drugs used to treat neoplastic cells harm normal living cells in different ways. CP is a chemotherapy drug that is used to treat cancer. It is inactive in vitro, but when activated by liver microsomal enzymes in vivo, it can successfully kill cells in the proliferative cycle. As well as some rapidly proliferating normal tissue cells, are killed by CP. CP was discovered to have a number of negative side effects, including a reduction in body resistance, a decrease in immune function, and the induction of oxidative damage (Ran et al, 2020). Nephrotoxicity, neurotoxicity, testicular dysfunction, cardiotoxicity, and hepatotoxicity are some of the more relevant side effects (Abdallah et al, 2019)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call